Clinical management of chemotherapy for elderly gynecological cancer patients

被引：4

作者：

Yoshida, Yoshio ^{[1
]}

Inoue, Daisuke ^{[1
]}

机构：

[1] Univ Fukui, Dept Obstet & Gynecol, 23-3 Matsuoka Shimoaizuki, Eiheiji, Fukui 9101193, Japan

来源：

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH | 2021年 / 47卷 / 07期

关键词：

chemotherapy; elderly cancer patient; geriatric assessment; geriatric oncology; gynecological cancer;

D O I：

10.1111/jog.14804

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Aim Since there are no established guidelines for the treatment of gynecological cancer in the elderly, medical treatment policy is currently decided by discussion with patients and their families based on doctors' experiences, referring to data from nonelderly patients and healthy elderly patients. The aim of this review was to clarify the current position of chemotherapy for elderly gynecological cancer patients and discuss the problems to be addressed in the future. Methods Little evidence has been accumulated for anticancer drug treatment in elderly individuals with gynecological cancer. This review presents outlines and representative papers on general cancer chemotherapy for the elderly, and problems that need to be solved in gynecological cancer fields in the future are identified. Results In 2018, the American Society of Clinical Oncology (ASCO) published guidelines for "Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology Summary". This guideline emphasizes that, when administering chemotherapy to patients over 65 years of age, vulnerabilities should be identified using geriatric assessment (GA). However, there have been no reports of clinical studies using GA in patients with cervical or uterine cancers, and only a few clinical studies using GA have been reported in patients with ovarian cancer. Conclusions Scoring systems suitable for elderly Japanese patients remain lacking. A Japanese gynecological GA needs to be developed in cooperation with other disciplines.

引用

页码：2261 / 2270

页数：10

共 45 条

[1] Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer [J].

Aghajanian, Carol ;

Goff, Barbara ;

Nycum, Lawrence R. ;

Wang, Yan V. ;

Husain, Amreen ;

Blank, Stephanie V. .

GYNECOLOGIC ONCOLOGY, 2015, 139 (01) :10-16

[2] OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [J].

Aghajanian, Carol ;

Blank, Stephanie V. ;

Goff, Barbara A. ;

Judson, Patricia L. ;

Teneriello, Michael G. ;

Husain, Amreen ;

Sovak, Mika A. ;

Yi, Jing ;

Nycum, Lawrence R. .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (17) :2039-2045

[3] Adjuvant treatment of endometrial cancer today [J].

Aoki, Yoichi ;

Kanao, Hiroyuki ;

Wang, Xipeng ;

Yunokawa, Mayu ;

Omatsu, Kohei ;

Fusegi, Atsushi ;

Takeshima, Nobuhiro .

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (07) :753-765

[4] Treating Cancer in Older and Oldest Old Patients [J].

Colloca, G. ;

Corsonello, A. ;

Marzetti, E. ;

Balducci, L. ;

Landi, F. ;

Extermann, M. ;

Scambia, G. ;

Cesari, M. ;

Carreca, I. ;

Monfardini, S. ;

Bernabei, R. .

CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (13) :1699-1705

[5] Cancer statistics for adults aged 85 years and older, 2019 [J].

DeSantis, Carol E. ;

Miller, Kimberly D. ;

Dale, William ;

Mohile, Supriya G. ;

Cohen, Harvey J. ;

Leach, Corinne R. ;

Sauer, Ann Goding ;

Lemal, Ahmedin ;

Siegel, Rebecca L. .

CA-A CANCER JOURNAL FOR CLINICIANS, 2019, 69 (06) :452-467

[6] Risk factors for readmission in patients with ovarian, fallopian tube, and primary peritoneal carcinoma who are receiving front-line chemotherapy on a clinical trial (GOG 218): an NRG oncology/gynecologic oncology group study (ADS-1236) [J].

Duska, Linda R. ;

Java, James J. ;

Cohn, David E. ;

Burger, Robert A. .

GYNECOLOGIC ONCOLOGY, 2015, 139 (02) :221-227

[7] Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score [J].

Extermann, Martine ;

Boler, Ivette ;

Reich, Richard R. ;

Lyman, Gary H. ;

Brown, Richard H. ;

DeFelice, Joseph ;

Levine, Richard M. ;

Lubiner, Eric T. ;

Reyes, Pablo ;

Schreiber, Frederic J., III ;

Balducci, Lodovico .

CANCER, 2012, 118 (13) :3377-3386

[8] Efficacy and safety of niraparib as maintenance treatment in older patients (≥ 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial [J].

Fabbro, Michel ;

Moore, Kathleen N. ;

Dorum, Anne ;

Tinker, Anna, V ;

Mahner, Sven ;

Bover, Isabel ;

Banerjee, Susana ;

Tognon, Germana ;

Goffin, Frederic ;

Shapira-Frommer, Ronnie ;

Wenham, Robert M. ;

Hellman, Kristina ;

Provencher, Diane ;

Harter, Philipp ;

Palacio Vazquez, Isabel ;

Follana, Philippe ;

Pineda, Mario J. ;

Mirza, Mansoor R. ;

Hazard, Sebastien J. ;

Matulonis, Ursula A. .

GYNECOLOGIC ONCOLOGY, 2019, 152 (03) :560-567

[9] Development of a geriatric vulnerability score in elderly patients with advanced ovarian cancer treated with first-line carboplatin: a GINECO prospective trial [J].

Falandry, C. ;

Weber, B. ;

Savoye, A. -M. ;

Tinquaut, F. ;

Tredan, O. ;

Sevin, E. ;

Stefani, L. ;

Savinelli, F. ;

Atlassi, M. ;

Salvat, J. ;

Pujade-Lauraine, E. ;

Freyer, G. .

ANNALS OF ONCOLOGY, 2013, 24 (11) :2808-2813

[10] Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods [J].

Ferlay, J. ;

Colombet, M. ;

Soerjomataram, I. ;

Mathers, C. ;

Parkin, D. M. ;

Pineros, M. ;

Znaor, A. ;

Bray, F. .

INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (08) :1941-1953

← 1 2 3 4 5 →